Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine whether pharmacological treatment with
N-acetylcysteine improves central and peripheral cardiorespiratory control and physical
capacity in COPD patients with mild-to-moderate airflow obstruction.